Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Evans

Showing results (81-90 of 208) with videos related to

Pageof 21
Sort By:
Molecular Cancer Therapeutics|July 18, 2013
Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancerYezi Zhu, Chengfei Liu, Nagalakshmi Nadiminty, et al.
Cancers|March 10, 2017
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer TherapyVito Cucchiara, Joy C Yang, Vincenzo Mirone, et al.
Molecular Cancer Therapeutics|May 21, 2010
Effect of the specific Src family kinase inhibitor saracatinib on osteolytic lesions using the PC-3 bone modelJoy C Yang, Lanfang Bai, Stanley Yap, et al.
AJR. American Journal of Roentgenology|October 25, 2011
Pretreatment imaging can be used to select imaging guidance, ultrasound alone versus CT plus ultrasound, for percutaneous renal radiofrequency ablationJohn P McGahan, Shaun Loh, Evan Fitzgerald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2014
Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancerChengfei Liu, Wei Lou, Yezi Zhu, et al.
European Urology Open Science|June 7, 2023
The Metastatic Risk of Renal Cell Carcinoma by Primary Tumor Size and SubtypeSteven M Monda, Hansen T Lui, Manolis A Pratsinis, et al.
Clinical Transplantation|September 13, 2002
Initial report of bladder carcinoma following combined bladder-drained pancreas and kidney transplantationRalph A Highshaw, Hari S G R Tunuguntla, Richard V Perez, et al.
International Journal of Cancer|July 28, 2011
Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migrationLanfang Bai, Joy C Yang, Joon-ha Ok, et al.
The Journal of Urology|June 16, 2012
Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stageKirk A Keegan, Clayton W Schupp, Karim Chamie, et al.
Biomedicines|July 27, 2022
The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate CancerPengfei Xu, Logan J Wasielewski, Joy C Yang, et al.
Pageof 21

Showing results (81-90 of 208) with videos related to

Sort By:
Pageof 21
Molecular Cancer Therapeutics|July 18, 2013
Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancerYezi Zhu, Chengfei Liu, Nagalakshmi Nadiminty, et al.
Cancers|March 10, 2017
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer TherapyVito Cucchiara, Joy C Yang, Vincenzo Mirone, et al.
Molecular Cancer Therapeutics|May 21, 2010
Effect of the specific Src family kinase inhibitor saracatinib on osteolytic lesions using the PC-3 bone modelJoy C Yang, Lanfang Bai, Stanley Yap, et al.
AJR. American Journal of Roentgenology|October 25, 2011
Pretreatment imaging can be used to select imaging guidance, ultrasound alone versus CT plus ultrasound, for percutaneous renal radiofrequency ablationJohn P McGahan, Shaun Loh, Evan Fitzgerald, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2014
Niclosamide inhibits androgen receptor variants expression and overcomes enzalutamide resistance in castration-resistant prostate cancerChengfei Liu, Wei Lou, Yezi Zhu, et al.
European Urology Open Science|June 7, 2023
The Metastatic Risk of Renal Cell Carcinoma by Primary Tumor Size and SubtypeSteven M Monda, Hansen T Lui, Manolis A Pratsinis, et al.
Clinical Transplantation|September 13, 2002
Initial report of bladder carcinoma following combined bladder-drained pancreas and kidney transplantationRalph A Highshaw, Hari S G R Tunuguntla, Richard V Perez, et al.
International Journal of Cancer|July 28, 2011
Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migrationLanfang Bai, Joy C Yang, Joon-ha Ok, et al.
The Journal of Urology|June 16, 2012
Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stageKirk A Keegan, Clayton W Schupp, Karim Chamie, et al.
Biomedicines|July 27, 2022
The Immunotherapy and Immunosuppressive Signaling in Therapy-Resistant Prostate CancerPengfei Xu, Logan J Wasielewski, Joy C Yang, et al.
Pageof 21